메뉴 건너뛰기




Volumn 28, Issue 4, 2006, Pages 364-365

A novel treatment option of bipolar depression with psychotic and catatonic features

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; CREATINE KINASE; FLUVOXAMINE; HALOPERIDOL; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; PAROXETINE; QUETIAPINE; VALPROIC ACID;

EID: 33745244993     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2006.05.003     Document Type: Letter
Times cited : (17)

References (8)
  • 1
    • 0042978721 scopus 로고    scopus 로고
    • Catatonia in psychiatric classification: a home of its own
    • Taylor M.A., and Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160 (2003) 1233-1241
    • (2003) Am J Psychiatry , vol.160 , pp. 1233-1241
    • Taylor, M.A.1    Fink, M.2
  • 4
    • 3242714976 scopus 로고    scopus 로고
    • TMS and drugs
    • Ziemann U. TMS and drugs. Clin Neurophysiol 115 (2004) 1717-1729
    • (2004) Clin Neurophysiol , vol.115 , pp. 1717-1729
    • Ziemann, U.1
  • 5
    • 0042026401 scopus 로고    scopus 로고
    • What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis
    • Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 25' 5 (2002) 555-577
    • (2002) Behav Brain Sci , vol.25 , Issue.5 , pp. 555-577
    • Northoff, G.1
  • 7
    • 0026712110 scopus 로고
    • Risk for definite neuroleptic malignant syndrome: a prospective study in 223 consecutive in-patients
    • Hermesh H., Aizenberg D., Weizman A., Lapidot M., Mayor C., and Munitz H. Risk for definite neuroleptic malignant syndrome: a prospective study in 223 consecutive in-patients. Br J Psychiatry 161 (1992) 722-723
    • (1992) Br J Psychiatry , vol.161 , pp. 722-723
    • Hermesh, H.1    Aizenberg, D.2    Weizman, A.3    Lapidot, M.4    Mayor, C.5    Munitz, H.6
  • 8
    • 15744400568 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo controlled trial of quetiapine, in the treatment of bipolar I or II depression
    • for the Bolder Study Group
    • Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.G., et al., for the Bolder Study Group. A randomized, double-blind, placebo controlled trial of quetiapine, in the treatment of bipolar I or II depression. Am J Psychiatry 162 7 (2005) 1351-1360
    • (2005) Am J Psychiatry , vol.162 , Issue.7 , pp. 1351-1360
    • Calabrese, J.R.1    Keck Jr., P.E.2    Macfadden, W.3    Minkwitz, M.4    Ketter, T.A.5    Weisler, R.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.